Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
biotech
boston blog main
boston top stories
clinical trials
fda
new york blog main
new york top stories
pfizer
san francisco top stories
acute myeloid leukemia
adverum biotechnologies
akcea therapeutics
alder biopharmaceuticals
alnylam pharmaceuticals
ambit biosciences
amgen
andrew fire
athena countouriotis
boston
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
calcitonin gene-related peptide
chronic migraine
cormorant asset management
craig mello
daiichi sankyo
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
What
drug
3
×
gets
3
×
fda
new
afternoon
alnylam
alnylam’s
amgen
approval
approved
athena
biotech
cancer
candidates
ceo
chief
class
countouriotis
developed
financing
head
history
landmark
making
medical
medicine
medicines
mezzanine
migraine
million
names
nod
officer
ok
old
onpattro
pain
patisiran
pharmaceuticals
preventive
Language
Current search:
drug
×
" san francisco blog main "
×
gets
×
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
